Jakovac, H. (2020). COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?. American Journal of Physiology-Heart and Circulatory Physiology, 319. (4), H793-H796. doi: 10.1152/ajpheart.00506.2020
Jakovac, Hrvoje. "COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?." American Journal of Physiology-Heart and Circulatory Physiology, vol. 319, no. 4, 2020, pp. H793-H796. https://doi.org/10.1152/ajpheart.00506.2020
Jakovac, Hrvoje. "COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?." American Journal of Physiology-Heart and Circulatory Physiology 319, no. 4 (2020): H793-H796. https://doi.org/10.1152/ajpheart.00506.2020
Jakovac, H. (2020) 'COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?', American Journal of Physiology-Heart and Circulatory Physiology, 319(4), pp. H793-H796. doi: 10.1152/ajpheart.00506.2020
Jakovac H. COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?. American Journal of Physiology-Heart and Circulatory Physiology [Internet]. 2020 October 01 [cited 2024 August 31];319(4):H793-H796. doi: 10.1152/ajpheart.00506.2020
H. Jakovac, "COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?", American Journal of Physiology-Heart and Circulatory Physiology, vol. 319, no. 4, pp. H793-H796, October 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:933914. [Accessed: 31 August 2024]